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Abstract 
Human Mesenchymal Stem Cells (hMSCs) undergo senescence in lifespan. In most clinical trials, 
hMSCs experience long-term expansion ex vivo to increase cell number prior to transplantation, 
which unfortunately leads to cell senescence, hampering post-transplant outcomes.  
Hydrogen peroxide (H2O2) in vitro represents a rapid, time and cost-effective tool, commonly used 
as oxidative stress tantalizing the stem cell ability to cope with a hostile environment, recapitulating 
the onset and progression of cellular senescence. 
Here, H2O2 at different concentrations (ranging from 50 to 400 μM) and time exposures (1 or 2 
hours - h), was used for the first time to compare the behavior of human Adipose tissue-derived 
Stem Cells (hASCs) and human Wharton’s Jelly-derived MSCs (hWJ-MSCs), as representative of 
adult and perinatal tissue-derived stem cells, respectively. We showed timely different responses of 
hASCs and hWJ-MSCs at low and high subculture passages, concerning the cell proliferation, the cell 
senescence-associated β-Galactosidase activity, the capability of these cells to undergo passages, the 
morphological changes and the gene expression of tumor protein p53 (TP53, alias p53) and cyclin 
dependent kinase inhibitor 1A (CDKN1A, alias p21) post H2O2 treatments. 
The comparison between the hASC and hWJ-MSC response to oxidative stress induced by H2O2 is 
a useful tool to assess the biological mechanisms at the basis of hMSC senescence, but it could also 
provide two models amenable to test in vitro putative anti-senescence modulators and develop 
anti-senescence strategies. 
Key words: human mesenchymal stem cells; cell senescence; oxidative stress-induced premature senescence; 
hydrogen peroxide; Resazurin-based assay; senescence-associated β-galactosidase activity  
Introduction 
The human body continuously repairs damaged 
tissues and opposes senescence-related processes due 
to the peculiar properties of its resident stem cells. 
Human mesenchymal stem cells (hMSCs) in fact are 
able of self-renewal and multi-lineage differentiation 
and the equilibrium between these two events 
determines the stem cell fate and their roles in the 
human body [1]. They can be isolated and expanded 
in vitro from virtually all adult tissues [2], including 








[3], and also from several fetal and perinatal sources, 
as well as placenta [5], umbilical cord [6] and cord 
blood [7]. MSCs obtained from various sources differ 
in their biological characteristics [8,9], and their 
proteome and transcriptome profiles revealed source 
specific markers [10]. Moreover, diversity in 
multi-lineage differentiation potency and paracrine 
functions [8,9,11,12] determine different clinical 
applications of hMSCs [13]. Recently, hMSCs have 
been utilized for cell-based therapy in regenerative 
medicine to treat several injury and degenerative 
disorders, like Crohn's disease, diabetes mellitus, 
multiple sclerosis, myocardial infarction, liver failure, 
and rejection after liver transplant [14-21].  
Since cell-based therapy procedures usually 
require hundreds of million hMSCs for each treatment 
(http://www.clinicaltrials.gov), cells isolated from 
donors need to be expanded ex vivo for several culture 
passages to obtain a large amount of cells prior to 
transplantation [13,22].  
Unfortunately, as the function of hMSCs 
decreases with age in vivo [23,24], hMSCs, as well as 
all cultured primary cells [25], undergo cellular 
senescence along culture passages, with substantial 
decay in differentiation and self-renewal potential 
[22-24]. Premature senescence is a continuous process 
where cells share many molecular and functional 
characteristics, including changes in morphology, 
enhanced Senescence-Associated β-Galactosidase (SA 
β-Gal) activity, and permanent cell cycle arrest [22,26]. 
Oxidative stress, defined as an imbalance 
between the production of free radicals/Reactive 
Oxygen Species (ROS), and antioxidants [27], is 
thought to contribute significantly to DNA damage 
and cellular senescence [28-30]. According to the free 
radical or oxidative stress theory of aging [31], 
oxidative stress incurs when the cellular antioxidant 
defense systems fail to counteract ROS bringing them 
back to their basal levels.  
For this reason, hydrogen peroxide (H2O2) 
treatment is commonly used as a model for assessing 
cellular susceptibility to oxidative stress. Although 
hMSCs appear to efficiently handle oxidative stress, 
nevertheless they undergo premature senescence in 
vitro when exposed to H2O2 [32,33]. Understanding 
hMSC behavior in oxidative stress would be import-
ant to study how to postpone, anticipate or revert 
Oxidative Stress-Induced Premature Senescence 
(OSIPS) in hMSC cultures. 
It has been recently shown that OSIPS is a 
common feature in bone marrow hMSCs, the stem cell 
population that has been first isolated and 
characterized, with evidence ranging from 
morphological traits and SA β-Gal positivity to 
differential proteomic/metabolomic signatures in 
H2O2 exposed cells, as compared with untreated 
controls [34-37]. In hMSCs isolated from adipose 
tissue (hASCs), H2O2 was found to increase 
intracellular ROS production and to reduce 
antioxidant defenses (i.e. superoxide dismutase - SOD 
and glutathione synthetase - GSH) [38], hampering 
cell viability in a dose- and exposure time- dependent 
manner [38,39]. It has been recently shown that SOD2 
overexpression in ASCs promotes cell resistance to 
oxidative stress [40]. Moreover, H2O2 treatment 
provokes DNA breaks [41], raises SA β-Gal positive 
cells [42], alters the expression of senescent marker 
genes, as well as p53, p21, mitogen-activated protein 
kinase 14 (MAPK14, alias p38) and sirtuin 1 (SIRT1) 
[38,39,42], and increases apoptosis with a decline of 
pro-survival gene expression [38]. It has been recently 
shown that also human Wharton’s Jelly-derived 
MSCs (hWJ-MSCs) treated with H2O2 undergo 
premature senescence at early culture passages: these 
cells show typical changes in morphology [43], slow 
their proliferation [44,45], result positive for SA β-Gal 
[43,44], express typical senescence [43] and 
pro-apoptotic gene markers, while displaying a 
down-regulation of survival genes [44,46].  
The aim of the present study was to investigate 
and compare the effects of H2O2 on morphology, 
proliferation and senescence in hASCs and 
hWJ-MSCs, as representative of adult and perinatal 
tissues derived hMSCs, respectively. In particular, we 
investigated along time the effects of H2O2 supplied to 
hMSCs at different concentrations (ranging from 50 to 
400 μM), for 1 or 2 hours (h), at low and high 
subculture passages.  
The hASCs are commonly used in cell-based 
therapy since their isolation is minimally invasive and 
because they are abundant and rapid in proliferation. 
On the other hand, in the human body, these cells, as 
well as all other adult MSCs, exhibit an age- 
dependent decline in their repairing capacity, 
increasing their susceptibility to degenerative 
diseases, cell death and senescence processes. In fact, 
multiple studies showed that the age of tissue donors 
affects several properties of the cells [47-49]. In 
particular, aged hASCs are significantly compromised 
in their ability to support the vascular network 
formation, owing to alterations in angiogenic 
properties [50], and their genes, normally related to 
senescence, act as positive regulators of apoptosis 
[51].  
On the other hand, neonatal MSCs such as 
hWJ-MSCs, in their short prenatal life are not so 
influenced by age [52,53]. These cells express 
mesenchymal but not endothelial and hematopoietic 
markers [54,55] and display several features of 
embryonic stem cells (ESCs) although with a minor 




expression of pluripotency genes [56-58], explaining 
the lack of tumorigenicity of hWJ-MSCs [59,60]. 
The high efficiency of hWJ-MSC recovery 
compared with hASCs (1 to 5 × 104 cells/cm of 
umbilical cord, while 1 g of adipose tissue yields 
approximately 5 × 103 stem cells) [61,62], the minimal 
ethical concerns associated with their use, their ability 
to modulate immunological responses and the fact 
that they are from young donors make them an ideal 
source of MSCs for therapeutic applications in 
allogeneic settings. Moreover, hWJ-MSCs are 
preferable to other stem cells isolated from perinatal 
tissues (i.e. fetal membranes) because their isolation 
guarantees the absence of contaminating maternal 
cells [52]. 
Therefore, the comparison between the hASC 
and hWJ-MSC response to oxidative stress can be 
useful to study the biological mechanisms at the basis 
of hMSC senescence and could provide two OSIPS 
models amenable to test putative anti-senescence 
modulators and develop anti-senescence strategies.  
Materials and Methods  
A comprehensive overview of the experimental 
procedures that have been used in this study was 
described in Figure 1. 
 
 
Figure 1. Comprehensive overview of the experimental procedures. 
 
hASCs and hWJ-MSCs: harvesting and culture 
All tissue samples were obtained from subjects 
that gave their informed consent for inclusion before 
they participated in the study. The study was 
conducted in accordance with the Declaration of 
Helsinki, and the protocol was approved by the local 
Ethical Committees (CE) (S.Orsola-Malpighi 
University Hospital - project identification code: 
n.1645/2014, ref. 35/2014/U/Tess and Villalba 
Hospital - project identification code: 16076 of 
Bologna, Italy). hASCs have been isolated by 
Lipogems device (PCT/IB2011/052204) and 
characterized according to standard procedures and 
with ethical clearance, as previously described [63]. 
hASCs were cultured in alfa-Minimal Essential 
Medium (α-MEM, Carlo Erba Reagents, Milano, Italy) 
supplemented with 10% heat-inactivated Fetal Bovine 
Serum (FBS) (Gibco, Waltham, MA, USA), 1% 
Penicillin-Streptomycin Solution, 1% L-Glutamine 200 
mM (Carlo Erba Reagents) [64]. hWJ-MSCs have been 
isolated from umbilical cords from healthy donor 
mothers and characterized as previously described 
[65,66]; cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) low glucose (BioWhittaker 
Cambrex, Walkersville, MD, USA) supplemented 
with 10% FBS (Gibco) and 1% Penicillin-Streptomycin 
Solution. Both hASCs and hWJ-MSCs were 
maintained at standard culture conditions of 37°C 
with 5% carbon dioxide in a humidified atmosphere. 
The non-adherent cells were removed, medium was 
changed twice a week and at 80% confluency cells 
were detached by treatment with trypsin-EDTA 
(Sigma-Aldrich Co., St. Louis, MO, USA), maintained 
and expanded until desired experimental culture 
passages. Both hASCs and hWJ-MSCs were derived 
from four healthy donors. 
Hydrogen peroxide treatment  
In order to test hydrogen peroxide (H2O2, 
Sigma-Aldrich Co.) capacity to induce cell senescence, 
hASCs and hWJ-MSCs were treated with different 
H2O2 concentrations and then submitted to a 
Resazurin-based proliferation (Sigma-Aldrich Co.) or 
to a SA β-Gal (Sigma Aldrich Co.) assays. Cells were 
incubated at 37°C in complete cell culture medium 
containing H2O2 for 1 or 2 h. Untreated cells were 
considered as controls. In preliminary experiments, 
cells to be used for the cell counts and proliferation 
assay were exposed to five H2O2 concentrations (50, 
100, 150, 200 or 400 µM), while cells to be used for SA 
β-Gal assay, were treated with the same H2O2 
concentrations, except for the 50 µM. In the following 
experiment settings, H2O2 400 µM was excluded. 
Moreover, a gene expression analysis was performed 
after 48 h from the end of the H2O2 stimulus: hASCs 
and hWJ-MSCs were treated for 2 h with H2O2 150 or 
200 µM respectively. 
Cell count  
hASCs and hWJ-MSCs, both obtained from one 
healthy subject (subculture passages 9th and 8th, 
respectively), were used in three different experim-
ents: they were seeded in 24-well plates at the density 




of 4000 and 3500 cells/cm2, respectively. After 24 h in 
standard conditions, cells were exposed for 2 h at 
H2O2 50, 100, 150, 200 and 400 µM or unexposed 
(control cells) in technical duplicate. At the end of the 
treatment, fresh medium was added in all the wells 
and culture plates were incubated in standard 
conditions until the count test. At 24, 48 and 72 h from 
the end of the stimulus, cells were detached by 
trypsin-EDTA and resuspended in a medium with 
50% Eritrosyn B dye 0.2% in PBS (Sigma-Aldrich); 
counts were done under a light microscope at least 
twice with a Neubauer chamber (BRAND GmbH, 
Wertheim, Germany) and the cell number was calcu-
lated following the manufacturer’s specifications.  
Cell metabolic activity and proliferation  
To evaluate the proliferation as function of 
metabolic activity of the cells, the “In vitro toxicology 
assay kit - Resazurin based” (Sigma-Aldrich Co.) was 
used. In this assay, metabolically active cells reduce 
Resazurin (not-fluorescent and blue) to Resorufin 
(highly fluorescent and red). Resorufin is a 
water-soluble compound and its intrinsic fluorescence 
can be measured avoiding the cell lysis (necessary 
with tetrazolium-salt based assays, i.e. MTT test). This 
allows to monitor cell proliferation of the same 
sample over time [67]. A preliminary proliferation 
study was conducted in order to determine the hASC 
and hWJ-MSC adequate cell density for seeding (data 
not shown). On the basis of results, hASCs and 
hWJ-MSCs were seeded in quadruplicates in a 96-well 
plate (BD Biosciences, Milano, Italy) at 4000 cells/cm2 
or 3500 cells/cm2 respectively, in each experiment. 
To determine the hASC and hWJ-MSC growth 
curves and to compare their basal proliferation, both 
hASCs and hWJ-MSCs were recovered from 4 healthy 
subjects (passages of subculture spanning from 6th to 
14th and from 6th to 16th, respectively). Then, in order 
to preliminarily evaluate the toxicity of H2O2 
treatment, both hASCs and hWJ-MSCs (9th and 8th 
subculture passage, respectively) were obtained from 
one subject and cells were treated in a technical 
quadruplicate with H2O2 at 5 different concentrations 
(50, 100, 150, 200 and 400 µM) for 1 and 2 h. Later, in 
order to evaluate the effect of selected H2O2 
concentrations on hASC and on hWJ-MSC 
proliferation, experiments (in technical quadruplicate) 
were performed with cells obtained from 4 healthy 
subjects (passages of subculture spanning from 6th to 
14th and from 6th to 16th, respectively). Finally, to 
perform a comparative analysis of cell proliferation 
throughout four different culture passages in hASCs 
(6th, 9th, 11th and 14th) and in hWJ-MSCs (6th, 8th, 11th 
and 16th), three different experiments were performed 
with cells derived from the same subject at each 
studied culture passage. 
In every experimental test, after 24 h from the 
cell seeding in standard conditions, treated cells were 
exposed to H2O2 as described above and control cells 
were cultured in complete medium. At the end of 
treatment time, fresh complete medium with 
Resazurin reagent (at the ratio of 10:1 respectively) 
was added to each well and cells were incubated at 
37°C. As a negative control Resazurin solution was 
added to the medium without cells; we also included 
the totally reduced Resazurin to the medium without 
cells as a positive control. The fluorescence signal was 
measured with the Wallac 1420 Victor2 Multilabel 
Counter (Perkin Elmer, Waltham, MA, USA) at 
wavelength of 590 nm using an excitation wavelength 
of 560 nm. Fluorescence was measured after 2, 4, 24, 
48 and 72 h from the end of the treatment. The 
number of viable cells correlating with the magnitude 
of dye reduction was expressed as percentage of 
Resazurin reduction according to this formula: (FI 590 
of test agent - FI 590 of negative control)/(FI 590 of 
100% reduced of Resazurin - FI 590 negative control) × 
100 where FI is Fluorescence Intensity. 
Senescence-Associated β-Galactosidase assay 
To evaluate the SA β-Gal activity, the 
"Senescence Cells Histochemical Staining Kit" 
(Sigma-Aldrich Co.) was used. hASCs and hWJ-MSCs 
were seeded in 24-well plates (BD Biosciences) at the 
density of 4000 and 3400 cells/well, respectively. 
These specific cell densities were determined after a 
preliminary growth curve analysis (data not shown). 
After 24 h in standard conditions, cells were exposed 
to H2O2 as described above. A preliminary study was 
performed in triplicate for each treatment on hASCs 
and hWJ-MSCs derived from one subject (9th and 8th 
culture passage, respectively), and SA β-Gal assay 
was carried out after 24, 48 or 72 h from the end of the 
exposure to H2O2. Then SA β-Gal staining was 
investigated at 48 h using cells from three different 
subjects (n=3, culture passages ranging from 6th and 
9th) for each cell type. The assessment of SA β-Gal 
activity was carried out according to the 
manufacturer’s instructions and the positive blue 
staining was used as a biomarker of cellular 
senescence. The number of positive (blue) and 
negative (not colored) cells was counted in each 
sample in at least three random fields under a light 
microscope (at 200× magnification and bright field 
illumination) [68]. To avoid staining due to cell 
confluence rather than to proliferative senescence, 
assay was performed in sub-confluent cultures 
displaying comparable cell density. 




Capacity of cells to undergo passages post 
H2O2 treatments 
In order to test the remaining adhesion cell 
capacity after H2O2 treatment, when cultures reached 
80% confluency, cells were re-seeded in 24-well plates 
(BD Biosciences). Control cells were splitted with 1:3 
ratio, while H2O2-treated cells were seeded with 1:1 
ratio. Cells were analyzed the following days in order 
to identify the proliferation cell capacity and the 
complete growth arrest. 
Morphological analysis of senescent 
H2O2-treated cells 
Cells were analyzed for morphological 
characteristics and changes under a light microscope 
(at 40× and 200× magnification) before treatment with 
H2O2, after 1 o 2 h of exposure, after 48 h from the end 
of the treatment and after their re-seeding. Cell 
images were detected under bright field illumination 
with the Leica MC170 HD Imaging System. 
 
RNA extraction and RT-PCR 
Cells obtained from one individual healthy 
subject for hASCs or hWJ-MSCs were seeded in T75 
flasks at the density of 3500 cells/cm2. After 24 h in 
standard conditions, cells were exposed to H2O2 150 
µM (hASCs) or 200 µM (hWJ-MSCs) for 2 h. After 48 h 
from the end of the stimulus, total RNA was extracted 
from treated or untreated hMSCs using the RNeasy 
Mini Kit (QIAGEN, Valencia, CA, USA) and digested 
with RNase-free Deoxyribonuclease I (DNase I) 
(RNase-free DNase set, QIAGEN) following the 
manufacturer’s instructions. RNAs were 
reverse-transcribed as previously described [69], 
except for the temperature of the reaction that was 
37°C instead of 42°C. The success of the reaction was 
verified with glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) gene amplification as described in [70], 
except for 25 cycles instead of 45; GAPDH amplicon 
detection was performed by gel agarose electro-
phoresis, as described by Beraudi and coll. [71]. The 
experiment was repeated three times. 
Real time PCR  
For each experimental condition, 25 ng of cDNA 
were amplified using the SsoAdvanced Universal 
SYBR Green Supermix (Bio-Rad Laboratories, 
Hercules, CA, USA) in technical triplicates in a 
Bio-Rad CFX96 real-time thermal cycler (Bio-Rad 
Laboratories), as previously described [70]. Specific 
primers for p53 and p21 genes were designed by 
Bio-Rad and used following the manufacturer’s 
instructions (TP53 and CDKN1A, 20×, Bio-Rad 
Laboratories). Relative gene expression was 
determined by CFX Manager Software version 3.1 
(Bio-Rad Laboratories) using hypoxanthine 
phosphoribosyl transferase 1 (HPRT1), TATA box binding 
protein (TBP), GAPDH (20×, Bio-Rad Laboratories) as 
reference genes with the “delta-delta CT 
method”[72,73].  
Statistical analysis 
Data obtained from the in vitro toxicology assay 
were analyzed using one-way ANOVA followed by 
the Tukey HSD and Student’s T-test. Data obtained 
from cell count assay were analyzed using one-way 
ANOVA followed by the Tukey HSD. Data obtained 
from real time PCR were analyzed by the CFX 
Manager Software version 3.1 (Bio-Rad Laboratories). 
Results were considered statistically significant with a 
p-value < 0.05 and highly significant with a p-value < 
0.01.  
Results 
Basal cell proliferation and senescence: a 
comparison between human ASCs and 
WJ-MSCs 
As previously described, the Resazurin-based 
assay allowed a cell proliferation monitoring over- 
and real- time, due to the Resorufin atoxicity [67]. On 
the basis of preliminary evaluations on hASC and 
hWJ-MSC growth curves (data not shown), cells were 
seeded at different concentrations (4000 cells/cm2 and 
3500 cells/cm2, respectively) to perform proliferation 
experiments. In order to compare the cell metabolism 
of hASCs and hWJ-MSCs, results were expressed as 
growth rates, calculated as the percentage of 
Resazurin reduction at each time point divided by the 
percentage of reduction at the 2 h from the Resazurin 
inoculation. As shown in Figure 2A, the hWJ-MSC 
growth rate was significantly greater (at 48 h and 72 h 
time points, p<0.05) than the one detected for hASCs 
(approximately twice). Cells derived from four 
subjects were used in each experiment for both hASCs 
and hWJ-MSCs related assays (passages of subculture 
spanning from 6th to 14th and from 6th to 16th, 
respectively). Since basal metabolism was higher in 
hWJ-MSCs than in hASCs, in the following 
experiments we decided to analyze hASC and 
hWJ-MSC proliferation starting from 4 and 2 h from 
Resazurin administration, respectively. hMSC 
senescence in basal conditions was evaluated by SA 
β-Gal assay. Figure 2B shows the characteristic 
fibroblast-like morphology of both hASCs and 
hWJ-MSCs, cultured at the 9th and the 8th passage, 
respectively. After SA β-Gal staining, in both cell 
types only a small percentage of blue colored cells 
were appreciable (Figure 2C, black arrows).  






Figure 2. (A) Cell proliferation and senescence in hASCs and hWJ-MSCs: growth rate of hASCs (n=4) and hWJ-MSCs (n=4) expressed as mean ± standard error of 
the mean (SEM; *p<0.05). Typical hASC and hWJ-MSC morphology at 9th - and 8th culture passages respectively (B), and SA β-Gal staining in hASCs and hWJ-MSCs 
(C). Cells were analyzed under a light microscope and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System at 200× 
magnification. Scale bars: 100 μm. Representative blue cells, as markers of senescence, are indicated by black arrows. 
 
Preliminary screening of H2O2 treated cells: 
proliferation analysis  
hASCs and hWJ-MSCs cell count was performed 
after 24, 48 and 72 h from the end of H2O2 treatment 
(50, 100, 150, 200 and 400 μM) for 2h. Data shown in 
Figure 3 (Panels A and B) were expressed as growth 
rates, calculated as the cell number at each time point 
divided by the cell number of seeded cells. Results 
underline that, in each experimental point, both 
hASCs and hWJ-MSCs treated with H2O2 were less in 
number comparing with untreated cells in a dose- 
dependent manner. 
Moreover, a preliminary Resazurin based assay 
was performed to evaluate the toxicity of H2O2 on 
hASCs and hWJ-MSCs proliferation (derived from 
one subject at 9th and 8th subculture passage, 
respectively). The assay was performed after 
treatment with H2O2 at 5 different concentrations (50, 
100, 150, 200 and 400 µM) for 1 and 2 h. In Figure 3 
(Panels C and D) we show the percentage of 
Resazurin reduction in presence or absence of a 2-h 
H2O2 treatment until 72 h post-treatment, expressed 
as the mean of technical quadruplicates. H2O2 
treatment at 50, 100, 150 and 200 µM seems to act in a 
dose-dependent manner on cell metabolic activity in 
both the hMSC types, while 400 µM H2O2 induced an 
evident cell proliferation arrest in hASCs (Figure 3C). 
Similar results were obtained when H2O2 was 
administered for 1 h (data not shown).  
In order to compare hASCs and hWJ-MSCs 
behavior, we decided to exclude the 400 µM higher 
concentration from the subsequent experimental plan.  
Effect of H2O2 on hASC proliferation 
We analyzed hASC proliferation up to 72 h 
following the termination of 1- or 2-h treatment in the 
presence of H2O2 at concentrations ranging from 50 to 
200 µM. Cells were obtained from four healthy 
subjects (passages of subculture spanning from 6th to 
14th). We observed a decrease in the percentage of 
Resazurin reduction in H2O2-treated cells compared 
with untreated cells (Figure 4). After 1 h of H2O2 
treatment (Figure 4, light grey lines), the differences 
between treated and untreated (control) cells were 
statistically significant (p<0.05) at 48 h when 
treatment was in the presence of 150 µM H2O2 (Figure 
4C), or at both 48 and 72 h when 200 µM H2O2 was 
used (Figure 4D). Cell exposure to H2O2 for 2 h 
(Figure 4, dark grey lines), further enhanced the 
significance of experimental outcomes. In particular, 
while among the lower concentrations (50 and 100 
µM), 100 µM H2O2 affected proliferation (p<0.05) after 
24 h (Figure 4A and 4B), a 2-h treatment with higher 
concentrations (150 and 200 µM) of H2O2 significantly 
decreased cell proliferation at multiple time points: 
after 24 (p<0.01) and 48 (p<0.05) h from the treatment 
with both 150 µM and 200 µM H2O2, and even after 72 
h (p<0.05) in cells exposed to this latter concentration 
(Figure 4C and 4D).  
 





Figure 3. Panels A and B: hASCs (A) and hWJ-MSCs (B) cell counts, expressed as growth rates, calculated as the cell number at each time point divided by the cell 
number of seeded cells. Data are expressed as mean of growth rates ± SD (n=3, *p<0.05, **p<0.01). Panels C and D: percentage of reduction of Resazurin (as 
indicator of cell proliferation) after treatment of hASCs (C) and hWJ-MSCs (D) for 2 h with H2O2 (50, 100, 150, 200 or 400 µM). Analysis was conducted on a 
technical quadruplicate at 4, 24, 48, 72 h (C) or at 2, 24, 48, 72 h (D) from the end of the treatment and data are expressed as mean ± SD. 
 
 
Figure 4. hASC proliferation curves after treatments with H2O2 at concentrations of 50 µM (A), 100 µM (B), 150 µM (C) and 200 µM (D) for 1 or 2 h. Analysis was 
conducted at 4, 24, 48, 72 h from the end of the treatment; data are expressed as mean of percentage of reduction of Resazurin (n=4, culture passages 6th- 14th) ± 
SEM, *p<0.05, **p<0.01. CTR is control. 





Since the presence of 200 µM H2O2 for 2-h 
treatment induced in hASCs the most evident 
reduction of cell proliferation, we also decided to 
perform comparative analysis of cell proliferation 
throughout four different culture passages (p6, p9, 
p11 and p14), in which these cells may intrinsically 
differ in senescence susceptibility, following a 2-h 
treatment in the presence of 200 µM H2O2. As shown 
in Figure 5, we observed that, irrespective of the time 
spent in culture at different passages, H2O2-exposed 
hASCs shared a similar proliferation decrease in 
comparison with the related control cells. 
Effect of H2O2 on hWJ-MSC proliferation 
In Figure 6, we show the proliferation curves of 
hWJ-MSCs treated for 1 and 2 h with H2O2 at 
concentrations ranging from 50 to 200 µM. Cells were 
obtained from four healthy subjects (passages of 
subculture spanning from 6th to 16th). H2O2 at 50, 100 
and 150 µM had a weak effect on hWJ-MSCs (Figure 
6A, 6B and 6C), while a 2-h exposure to the higher 
concentration of H2O2 (200 µM) resulted in a 
significant decrease in the percentage of Resazurin 
reduction, as compared with control cells. This was 
evident at 24, 48 and 72 h following termination of the 
H2O2 treatment (p<0.05) (Figure 6D).  
As for hASCs, we analyzed cell proliferation in 
hWJ-MSCs throughout four distinct subculture 
passages (p6, p8, p11 and p16): it was evident that 
exposed and unexposed cells exhibited a differential 
response as a function of the time spent in culture 
(Figure 7). In fact, in early passages (i.e. p6) 
proliferation was not affected from the treatment at 
any time point. In contrast, in late passages (i.e. p11 
and p16) proliferation always decreased in treated 
cells compared with control cells (Figure 7). 
Effect of H2O2 on hASC SA β-Galactosidase 
activity 
We first evaluated the H2O2 effect on SA β-Gal 
activity in hASCs (at subculture passage 9th) 
recovered from one healthy subject (in technical 
triplicate). H2O2 was used at the final concentrations 
of 100, 150, 200 and 400 µM for 1 and 2 h, and the 
assay was performed after 24, 48 and 72 h from the 
termination of the stimuli. At each experimental time 
point, 400 µM H2O2 produced a toxic effect and for 
this reason such a high concentration was not used for 
the assessment of SA β-Gal expression (data not 
shown). In all investigated conditions, H2O2 increased 
the enzyme activity in comparison with the related 
controls (considered as a value of 1) (Figure 8A and 
Figure 8B). We arbitrarily defined a ratio greater than 
3 in the percentage of blue cells in treated versus 
control hASCs as a proof for the effectiveness of the 
treatment. Under these experimental conditions, after 
1 h of exposure only 150 or 200 µM H2O2 raised SA 
β-Gal staining at 48 h from the termination of the 
treatment (Figure 7A). On the contrary, after a 2-h 
treatment all the H2O2 concentrations tested 
efficaciously increased SA β-Gal 
activity at 48 h from the end of 
treatment, with a more prolong-
ed effect lasting up to 72 h when 
a concentration of 200 µM H2O2 
was used (Figure 7B).  
After a critical analysis of 
this preliminary test, we further 
explored SA β-Gal activity after 
48 h from the end of H2O2 
treatment in cells that had been 
recovered from three healthy 
subjects (at subculture passages 
6th-9th): in Figure 8 we also show 
results from a representative 
experiment (Figure 8C) and the 
corresponding culture images of 
H2O2 2-h exposure (Figure 8D). 
We found that the percentage of 
blue cells after each treatment 
was greater than in controls 
(Figure 8C) and that it reached a 





Figure 5. Comparison of cell proliferation between hASCs cultured in the absence (CTR) and presence of H2O2 
at four subculture passages (p6, p9, p11 and p14). Treated cells were incubated with 200 µM H2O2 for 2 h. Data 
were expressed as mean of percentage of reduction of Resazurin (technical triplicate) ± SD; *p<0.05. 





Figure 6. hWJ-MSC proliferation curves after treatment with H2O2 at concentrations of 50 µM (A), 100 µM (B), 150 µM (C) and 200 µM (D) for 1 or 2 h. Analysis 
was conducted at 2, 24, 48, 72 h from the end of the treatment; data are expressed as mean of percentage of reduction of Resazurin (n=4, culture passages 6th- 16th) 
± SEM, *p<0.05. CTR is control. 
 
 
Figure 7. Comparison of cell proliferation between hWJ-MSCs cultured in the absence (CTR) and presence of H2O2 at four subculture passages (p6, p8, p11 and 
p16). Treated cells were incubated with 200 µM H2O2 for 2 h. Data were expressed as mean of percentage of reduction of Resazurin (technical triplicate) ± SD; 
*p<0.05. 
 





Figure 8. hASC SA β-Gal activity after H2O2 treatment. Effect of H2O2 treatment expressed in term of ratio between the percentage of blue cells in treated sample 
and the relative percentage of blue cells in untreated sample after 1 h (Panel A) and 2 h (Panel B) of treatment. In each panel the effect of every H2O2 concentration 
was presented after 24, 48 and 72 h from the end of the stimulus. Data were obtained in triplicate from one subject and expressed as ratio (n=3) ± SD. Control value 
is 1 (not shown) and treatment was arbitrarily considered effective when ratio was >3. In Panels (C) and (D) the effects of different H2O2 concentrations on hASC 
SA β-Gal activity tested at 48 h from the end of the treatment are shown. In Panel (C), a graph representative of three (obtained from three different subjects) 
showing the percentage of blue cells in untreated (CTR) and treated cells after 1 and 2 h of H2O2 treatment. Data were expressed as percentage of blue cells ± SD. 
Panel (D): representative SA β-Gal staining images of hASCs untreated (CTR) and treated with H2O2 at final concentrations of 100 µM, 150 µM and 200 µM after 2-h 
treatment. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 
HD Imaging System. Blue staining indicates senescent cells and scale bars correspond to 100 μm. 
 
Effect of H2O2 on hWJ-MSCs SA 
β-Galactosidase activity 
A preliminary SA β-Gal activity assay was 
performed in technical triplicate also on hWJ-MSCs 
(recovered from one healthy subject and at subculture 
passage 8th) after 24, 48 and 72 h from termination of 
the H2O2 treatment at concentrations of 100, 150, 200 
and 400 µM for 1 and 2 h. As seen for hASCs, cells 
treated with H2O2 400 µM were not analyzed due to 
the cytotoxicity of the treatment (data not shown). 
In all experimental conditions, H2O2 treatments 
(as compared with controls, corresponding to a value 
1) increased the enzyme activity, and consequently 
the percentage of blue stained senescent cells (Figure 
9). The effectiveness of treatment was arbitrarily 
defined as reported in the paragraph “Effect of H2O2 
on hASCs SA β-Galactosidase activity”. We found 
that the most pronounced effect was detected at 48 h 
from the end of the treatments: after 1 h of exposure, 
an increase in the number of positive blue cells could 
only be observed in the presence of 200 µM H2O2 
(Figure 9A), while when cells were treated for 2 h, all 
H2O2 concentrations were effective (Figure 9B). Based 
upon these results, SA β-Gal activity was assessed 
after 48 h from the end of the H2O2 treatments in 
hWJ-MSCs harvested from three healthy subjects (at 




subculture passages 6th-9th): in Figure 9, we also show 
results from a representative experiment (Figure 9C) 
and the corresponding culture images of H2O2 2-h 
exposure (Figure 9D). H2O2 administration gave an 
increased percentage of blue cells in comparison with 
control hWJ-MSCs (Figure 9C). This augmentation 
was dependent upon both the concentration used and 
the duration of treatment.  
Capacity of cells to undergo passages and 
morphological changes post H2O2 treatments 
All investigated cell types were able to undergo 
culture passages post-H2O2 administration, revealing 
differences related to H2O2 concentrations. In fact, 
while the hMSC growth was found to be slowed 
down after treatment with H2O2 400 µM, and the cells 
were not further viable on re-plating, cells that had 
been treated with 100, 150 and 200 µM H2O2 were still 
able to undergo at least 2 passages. Furthermore, after 
increasing H2O2 concentration and time of exposure, 
hASCs and hWJ-MSCs changed their morphology at 
the end of the treatment, at 48 h post treatment and 
after the re-seeding (Figure 10 and 11). In particular, 
hASCs become thinner and longer (Figure 10), while 
hWJ-MSCs enlarged and ramified (Figure 11). 
 
 
Figure 9. hWJ-MSC SA β-Gal activity after H2O2 treatment. Effect of H2O2 treatment expressed in term of ratio between the percentage of blue cells in treated 
sample and the relative percentage of blue cells in untreated sample after 1 h (Panel A) and 2 h (Panel B) of treatment. In each panel the effect of every H2O2 
concentration was presented after 24, 48 and 72 h from the end of the stimulus. Data were obtained in triplicate from one subject and expressed as ratio (n=3) ± SD. 
Control value is 1 (not shown) and treatment was arbitrarily considered effective when ratio was >3. In Panels (C) and (D) the effects of different H2O2 
concentrations on hWJ-MSC SA β-Gal activity tested at 48 h from the end of the treatment are shown. In Panel (C), a graph representative of three (obtained from 
three different subjects) showing the percentage of blue cells in untreated (CTR) and treated cells after 1 and 2 h of H2O2 treatment. Data were expressed as 
percentage of blue cells ± SD. Panel (D): representative SA β-Gal staining images of hWJ-MSCs untreated (CTR) and treated with H2O2 at final concentrations of 100 
µM, 150 µM and 200 µM after 2-h treatment. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field 
illumination with the Leica MC170 HD Imaging System. Blue staining indicates senescent cells and scale bars correspond to 100 μm. 
 





Figure 10. Morphological changes of hASCs after reseeding post H2O2 treatments: control (CTR) cells and cells treated with H2O2 100, 150 and 200 µM. Cells were 
analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System. 
Scale bars: 100 μm. 
 
 
Figure 11. Morphological changes of hWJ-MSCs after reseeding post H2O2 treatments: control (CTR) cells and cells treated with H2O2 100, 150 and 200 µM. Cells 
were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging 
System. Scale bars: 100 μm. 
 
Effect of H2O2 on hMSCs gene expression 
p21 and p53 expression was investigated at 48 h 
from the end of the H2O2 specific treatment both in 
hASCs (i.e. 150 µM for 2 h) and hWJ-MSCs (i.e. 200 µM 
for 2 h). As depicted in Figure 12, hydrogen peroxide 
strongly acted on p21 overexpression in hMSCs 
independently of their source (p<0.01). At the same 
time, H2O2 treatment in hASCs resulted in a down 
regulation of p53 (Figure 12A), while in hWJ-MSCs it 
shows a stable expression in comparison with the 
control (Figure 12B). 
Discussion  
Both hASCs and hWJ-MSCs are frequently used 
in stem cell-based protocols [2]. These cells undergo 
significant decline in their rescuing potential as they 
age in vivo during the lifespan, or when they become 
senescent during their expansion in vitro, with 
significant impairment in the outcome of cell therapy 
efforts [22-24]. 
The availability of reliable accelerated methods 
to induce stem cell senescence in vitro will avoid 




cumbersome long-lasting (2-3 months) culture 
protocols and facilitate the investigation of senescence 
mechanisms and source-related senescence suscepti-
bility among different hMSC populations [13]. 
To this end, we observed that hASCs and 
hWJ-MSCs exhibited different proliferation profiles 
over time, indicating that basal metabolism may be 
higher in hWJ-MSCs than in hASCs. Akin to this 
observation is the present finding that hWJ-MSCs 
required a greater number of culture passages than 
hASCs for undergoing senescence, as it can also be 
inferred from the ability of hWJ-MSCs to exhibit 
long-lasting stemness properties and preserve a 
typical fibroblast-like morphology while undergoing 
multiple culture passages in vitro [43,74].  
Here, we found that in both cell populations, 
H2O2 not only inhibited cell proliferation in a 
dose-dependent fashion, but it also affected the 
persistence of the anti-proliferative effect after the end 
of exposure (up to 48 or 72 h) in a manner that was 
dependent upon the duration (1 or 2 h) of the 
treatment itself. These results are coherent with the 
reduction of cell vitality observed in hWJ-MSCs 
[43-45] and hASCs [39,42] treated with higher 
concentrations of H2O2 (until 2000 µM) but at low 
subcultured passages. We also observed a growth 
slowdown of cells treated with H2O2 400 µM, and a 
cell inability to re-plate. On the other hand, cells 
treated with 100, 150 and 200 µM H2O2 were still able 
to undergo at least 2 passages, although an increase in 
H2O2 concentration and exposure time were 
associated to morphology changes. These results were 
consistent with those obtained in the study of Choo 
and coll. (2014), where hWJ-MSCs exposed to H2O2 
resulted enlarged, with cytoplasm enriched of 
granules and able to undergo until 3-4 passages after 
H2O2 treatment [43]. 
The possibility that the observed difference in 
basal proliferative activity among hASCs and 
hWJ-MSCs may entail different senescence suscepti-
bilities [13,75] was confirmed by the finding that the 
same H2O2 concentrations that remarkably inhibited 
proliferation in hASCs, only weakly affected 
hWJ-MSC proliferation, and that a significant 
decrease in the percentage of reduced Resazurin 
could be achieved in these cells solely after the 
exposure to the H2O2 concentration that proved the 
most effective one in hASCs. Our results are 
reinforced by the previous evidence that low H2O2 
concentrations (50 and 100 µM) did not affect 
hWJ-MSCs proliferation treated for 24 h [45].  
The analysis of the effect of H2O2 treatment on 
proliferation in cells that had been subjected to 
different, even long-term subculture passages (until 
14-16th), provided the chance of further compounding 
the multifaceted ways different hMSC populations 
may progress in senescence. For the first time we 
demonstrated that H2O2 given for 2 h, reduced hASC 
proliferation both in early and late subculture 
passages, while it decreased hWJ-MSC proliferation 
in a passage-dependent fashion, in particular only at 
higher subculture passages.  
These observations were all corroborated by 
results obtained from our analysis of SA β-Gal activity 
after 24, 48 and 72 h from the end of the H2O2 
treatment, where both hASCs and hWJ-MSCs showed 
an increase of the SA β-Gal activity. In particular, the 
higher senescent effect was evident at 48 h. A similar 
trend was seen in other researches, although it was 
obtained at different experimental times [42-44].  
Comparing SA β-Gal assay results, it is evident 
that hWJ-MSCs and hASCs have a different way to 
respond to oxidative stress. To this end, the SA β-Gal 
activity increase observed in hWJ-MSCs was 
dependent on both H2O2 concentration and exposure 
time, reaching a maximum with 200 µM 
H2O2 for 2 h, while hASCs showed the 
greatest increase with 150 µM H2O2. In 
fact, if hASCs were exposed to H2O2 at 
low concentrations (i.e. 100 µM) they 
were able to counteract pro-senescence 
stress, while if cells were treated with 
200 µM H2O2 they showed a SA β-Gal 
activity increase, although weaker than 
that induced by 150 µM H2O2. This 
observation could be explained by the 
well documented ability of H2O2 to 
promote not only senescence but also 
apoptosis depending upon the 
experimental conditions [43,76].  
The persistence of the hydrogen 
peroxide effects on cell senescence was 
shown also by the gene expression 
 
 
Figure 12. Gene expression analysis in hASCs and hWJ-MSCs after 48 h from 2h-H2O2 treatment. A: 
p21 and p53 relative expression in hASCs treated with 150 µM H2O2. B: p21 and p53 relative 
expression in hWJ-MSCs treated with 200 µM H2O2. Data were expressed as mean fold change (n=3) 
± SD, **p<0.01. 




analysis of two of the major cell cycle regulators, p21 
and p53. At 48 h from the end of the most effective and 
specific H2O2 treatment, in both hMSC types the 
inhibition of cell cycle progression was associated 
with a strong overexpression of p21, a transient 
growth arrest mediator, able to slowdown cell 
proliferation [22]. At the same time, p53 transcription 
was quite stable in hWJ-MSCs, while being 
down-regulated in hASCs, suggesting that after 2 
days from the selected H2O2 administration, hMSCs 
did not start an apoptotic program.  
Overall the present data not only provide 
evidence for the effectiveness of the H2O2 exposure 
method in recapitulating over time senescence 
features in hMSCs, but also indicate its usefulness in 
detecting the proneness of different hMSC 
populations to undergo senescence on the basis of 
their tissue source [13,73]. 
In particular, hWJ-MSCs present several 
advantages comparing with hASCs: not only their 
easy availability and isolation, their independence 
from donor age, but also their natural proneness to 
undergo senescence at late culture passages and their 
ability to efficiently counteract oxidative stress stimuli.  
Moreover, within cell therapy contexts, the 
present study may also set the basis to investigate and 
establish the limit(s) for in vitro expansion of targeted 
hMSC populations in order to achieve an optimal 
balance between the cell number available for 
transplantation and the risk for cell expansion-related 
senescence. These considerations may also apply to 
the development of patient-specific protocols for the 
expansion of defined hMSC populations in the future 
perspective of Precision Medicine approaches.  
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